Heparinex, L.L.C. Company Profile
Heparinex, L.L.C. is a biopharmaceutical company focusing on the novel recombinant synthesis of compounds for a number of markets, including drug delivery, dermal fillers, reconstructive surgery, biomaterials, cosmetics, medical devices and ophthalmic medical applications. The core technology platform was originally discovered and patented by leading carbohydrate chemist/ glycobiologist, Paul DeAngelis, PhD, Heparinex Chief Scientist and professor at the University of Oklahoma Health Sciences Center.
News Articles
None
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Heparinex, L.L.C. is a biopharmaceutical company focusing on the novel recombinant synthesis of compounds for a number of markets, including drug delivery, dermal fillers, reconst...
Caisson Biotech is a wholly owned subsidiary of Heparinex, L.L.C. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increa...
Caisson Biotech is a wholly-owned subsidiary of Heparinex, L.L.C. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increa...
More Information about "Heparinex, L.L.C." on BioPortfolio
We have published hundreds of Heparinex, L.L.C. news stories on BioPortfolio along with dozens of Heparinex, L.L.C. Clinical Trials and PubMed Articles about Heparinex, L.L.C. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heparinex, L.L.C. Companies in our database. You can also find out about relevant Heparinex, L.L.C. Drugs and Medications on this site too.
